Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Creese

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Molecular Pharmacology|May 1, 1983
Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptorsD R Sibley, I Creese
European Journal of Pharmacology|June 15, 1979
Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol bindingI Creese, S H Snyder
Molecular Pharmacology|July 1, 1989
Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenololM A Riva, I Creese
Molecular Pharmacology|July 1, 1989
Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatmentM A Riva, I Creese
Nature|November 10, 1977
A simple and sensitive radioreceptor assay for antischizophrenic drugs in bloodI Creese, S H Snyder
Molecular Pharmacology|February 1, 1985
Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptorS E Leff, I Creese
Psychopharmacology Bulletin|January 1, 1986
Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390E J Hess, I Creese
Advances in Experimental Medicine and Biology|January 1, 1986
Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390E J Hess, I Creese
Psychopharmacology Bulletin|October 1, 1975
Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?I Creese, S D Iversen
Clinical Neuropharmacology|January 1, 1986
Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophreniaI Creese, E J Hess
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Molecular Pharmacology|May 1, 1983
Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptorsD R Sibley, I Creese
European Journal of Pharmacology|June 15, 1979
Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol bindingI Creese, S H Snyder
Molecular Pharmacology|July 1, 1989
Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenololM A Riva, I Creese
Molecular Pharmacology|July 1, 1989
Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatmentM A Riva, I Creese
Nature|November 10, 1977
A simple and sensitive radioreceptor assay for antischizophrenic drugs in bloodI Creese, S H Snyder
Molecular Pharmacology|February 1, 1985
Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptorS E Leff, I Creese
Psychopharmacology Bulletin|January 1, 1986
Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390E J Hess, I Creese
Advances in Experimental Medicine and Biology|January 1, 1986
Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390E J Hess, I Creese
Psychopharmacology Bulletin|October 1, 1975
Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?I Creese, S D Iversen
Clinical Neuropharmacology|January 1, 1986
Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophreniaI Creese, E J Hess
Pageof 15